|
C6ORF57 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.447800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.517820E-03 |
| Normal-vs-Stage2 |
1.129670E-02 |
| Normal-vs-Stage3 |
6.220700E-04 |
| Normal-vs-Stage4 |
6.221200E-03 |
| Stage1-vs-Stage2 |
7.184000E-01 |
| Stage1-vs-Stage3 |
3.552400E-01 |
| Stage1-vs-Stage4 |
6.424400E-01 |
| Stage2-vs-Stage3 |
7.837800E-01 |
| Stage2-vs-Stage4 |
9.486600E-01 |
| Stage3-vs-Stage4 |
8.360400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.761600E-04 |
| Normal-vs-AfricanAmerican |
1.770990E-01 |
| Normal-vs-Asian |
6.577000E-03 |
| Caucasian-vs-AfricanAmerican |
3.771400E-01 |
| Caucasian-vs-Asian |
8.526600E-01 |
| AfricanAmerican-vs-Asian |
3.803600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.982700E-04 |
| Normal-vs-Female |
1.583660E-03 |
| Male-vs-Female |
3.246000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.420100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.659700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.774500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.494200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.506400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.341400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.335800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.867800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.023600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.426200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.977800E-01 |
| Classical-VS-Follicular |
8.116600E-01 |
| Classical-VS-Other |
6.340400E-01 |
| Classical-VS-Normal |
1.218330E-03 |
| Tall-VS-Follicular |
5.901000E-01 |
| Tall-VS-Other |
4.799800E-01 |
| Tall-VS-Normal |
5.285600E-02 |
| Follicular-VS-Other |
7.519400E-01 |
| Follicular-VS-Normal |
8.883500E-03 |
| Other-VS-Normal |
9.070300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.781400E-04 |
| Normal-vs-N1 |
4.027700E-04 |
| N0-vs-N1 |
3.282800E-01 |
|
|
